Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain (original) (raw)
- Letter
- Published: 10 February 2008
- Zhen-Zhong Xu1 na1,
- Xiaoying Wang2 na1,
- Jong Yeon Park1,
- Zhi-Ye Zhuang1,
- Ping-Heng Tan1,
- Yong-Jing Gao1,
- Kristine Roy3,
- Gabriel Corfas3,
- Eng H Lo2 &
- …
- Ru-Rong Ji1
Nature Medicine volume 14, pages 331–336 (2008)Cite this article
- 5668 Accesses
- 613 Citations
- 10 Altmetric
- Metrics details
Abstract
Treatment of neuropathic pain, triggered by multiple insults to the nervous system, is a clinical challenge because the underlying mechanisms of neuropathic pain development remain poorly understood1,2,3,4. Most treatments do not differentiate between different phases of neuropathic pain pathophysiology and simply focus on blocking neurotransmission, producing transient pain relief. Here, we report that early- and late-phase neuropathic pain development in rats and mice after nerve injury require different matrix metalloproteinases (MMPs). After spinal nerve ligation, MMP-9 shows a rapid and transient upregulation in injured dorsal root ganglion (DRG) primary sensory neurons consistent with an early phase of neuropathic pain, whereas MMP-2 shows a delayed response in DRG satellite cells and spinal astrocytes consistent with a late phase of neuropathic pain. Local inhibition of MMP-9 by an intrathecal route inhibits the early phase of neuropathic pain, whereas inhibition of MMP-2 suppresses the late phase of neuropathic pain. Further, intrathecal administration of MMP-9 or MMP-2 is sufficient to produce neuropathic pain symptoms. After nerve injury, MMP-9 induces neuropathic pain through interleukin-1β cleavage and microglial activation at early times, whereas MMP-2 maintains neuropathic pain through interleukin-1β cleavage and astrocyte activation at later times. Inhibition of MMP may provide a novel therapeutic approach for the treatment of neuropathic pain at different phases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Ji, R.R. & Strichartz, G. Cell signaling and the genesis of neuropathic pain. Sci. STKE 2004, reE14 (2004).
PubMed Google Scholar - Tsuda, M., Inoue, K. & Salter, M.W. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci. 28, 101–107 (2005).
Article CAS Google Scholar - Woolf, C.J. & Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959–1964 (1999).
Article CAS Google Scholar - Kehlet, H., Jensen, T.S. & Woolf, C.J. Persistent postsurgical pain: risk factors and prevention. Lancet 367, 1618–1625 (2006).
Article Google Scholar - Parks, W.C., Wilson, C.L. & Lopez-Boado, Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617–629 (2004).
Article CAS Google Scholar - Chattopadhyay, S., Myers, R.R., Janes, J. & Shubayev, V. Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve. Brain Behav. Immun. 21, 561–568 (2007).
Article CAS Google Scholar - Rosenberg, G.A. Matrix metalloproteinases in neuroinflammation. Glia 39, 279–291 (2002).
Article Google Scholar - Wang, X. et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037–7042 (2000).
Article CAS Google Scholar - Yong, V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931–944 (2005).
Article CAS Google Scholar - Zhao, B.Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441–445 (2006).
Article CAS Google Scholar - Kim, S.H. & Chung, J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355–363 (1992).
Article CAS Google Scholar - Zhuang, Z.Y. et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26, 3551–3560 (2006).
Article CAS Google Scholar - Levin, J.I. et al. The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines. Bioorg. Med. Chem. Lett. 11, 2975–2978 (2001).
Article CAS Google Scholar - Murphy, G. & Willenbrock, F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248, 496–510 (1995).
Article CAS Google Scholar - Coull, J.A. et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017–1021 (2005).
Article CAS Google Scholar - Raghavendra, V., Tanga, F. & DeLeo, J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624–630 (2003).
Article CAS Google Scholar - Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783 (2003).
Article CAS Google Scholar - Watkins, L.R., Milligan, E.D. & Maier, S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450–455 (2001).
Article CAS Google Scholar - Jin, S.X., Zhuang, Z.Y., Woolf, C.J. & Ji, R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017–4022 (2003).
Article CAS Google Scholar - Schonbeck, U., Mach, F. & Libby, P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 161, 3340–3346 (1998).
CAS PubMed Google Scholar - Samad, T.A. et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471–475 (2001).
Article CAS Google Scholar - Sweitzer, S., Martin, D. & DeLeo, J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103, 529–539 (2001).
Article CAS Google Scholar - Sung, C.-S. et al. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1β-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J. Neurochem. 94, 742–752 (2005).
Article CAS Google Scholar - Clark, A.K. et al. Rapid co-release of interleukin 1β and caspase 1 in spinal cord inflammation. J. Neurochem. 99, 868–880 (2006).
Article CAS Google Scholar - Inoue, M. et al. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10, 712–718 (2004).
Article CAS Google Scholar - Zhuang, Z.Y., Gerner, P., Woolf, C.J. & Ji, R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149–159 (2005).
Article Google Scholar - Dworkin, R.H. et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60, 1524–1534 (2003).
Article Google Scholar - Tan, P.H., Yang, L.C., Shih, H.C., Lan, K.C. & Cheng, J.T. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12, 59–66 (2005).
Article CAS Google Scholar - Chen, S. et al. Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat. Neurosci. 6, 1186–1193 (2003).
Article CAS Google Scholar
Acknowledgements
The work was supported in part by US National Institutes of Health grants R01-DE17794, R01-NS54362 and TW7180 to R.-R.J. and R01-NS37074, R01-NS48422, R01-NS56458, P01-NS55104 and P50-NS10828 to E.H.L. P.-H.T. was supported by a grant from E-DA Hospital/I-Shou University, Taiwan. We thank T. Kohno (Niigata University, Japan) for providing FR167653 compound and Q. Ma (Harvard Medical School) for critical reading of the manuscript.
Author information
Author notes
- Yasuhiko Kawasaki, Zhen-Zhong Xu and Xiaoying Wang: These authors contributed equally to this study.
Authors and Affiliations
- Department of Anesthesiology, Pain Research Center, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Medical Research Building, Room 604, Boston, 02115, Massachusetts, USA
Yasuhiko Kawasaki, Zhen-Zhong Xu, Jong Yeon Park, Zhi-Ye Zhuang, Ping-Heng Tan, Yong-Jing Gao & Ru-Rong Ji - Departments of Neurology and Radiology, Neuroprotection Research Laboratory, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Charlestown, 02129, Massachusetts, USA
Xiaoying Wang & Eng H Lo - Division of Neuroscience, Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, 02115, Massachusetts, USA
Kristine Roy & Gabriel Corfas
Authors
- Yasuhiko Kawasaki
You can also search for this author inPubMed Google Scholar - Zhen-Zhong Xu
You can also search for this author inPubMed Google Scholar - Xiaoying Wang
You can also search for this author inPubMed Google Scholar - Jong Yeon Park
You can also search for this author inPubMed Google Scholar - Zhi-Ye Zhuang
You can also search for this author inPubMed Google Scholar - Ping-Heng Tan
You can also search for this author inPubMed Google Scholar - Yong-Jing Gao
You can also search for this author inPubMed Google Scholar - Kristine Roy
You can also search for this author inPubMed Google Scholar - Gabriel Corfas
You can also search for this author inPubMed Google Scholar - Eng H Lo
You can also search for this author inPubMed Google Scholar - Ru-Rong Ji
You can also search for this author inPubMed Google Scholar
Contributions
Y.K. performed behavioral and immunohistochemical experiments; Z.-Z.X. conducted western blotting, DRG culture and zymography studies; X.W. performed zymography studies and contributed to project development; J.Y.P. conducted behavioral studies; Z.-Y.Z. conducted initial behavioral and histochemical studies; P.-H.T. designed siRNAs and initially tested MMP-9 siRNA; Y.-J.G. conducted ELISA studies and prepared astrocyte cultures; K.R. and G.C. contributed to electron microscopy studies; E.H.L. developed the project and provided critical review and comments on the manuscript. R.-R.J. developed and supervised the project, designed all the experiments, conducted some data analysis and prepared the manuscript.
Corresponding author
Correspondence toRu-Rong Ji.
Supplementary information
Rights and permissions
About this article
Cite this article
Kawasaki, Y., Xu, ZZ., Wang, X. et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.Nat Med 14, 331–336 (2008). https://doi.org/10.1038/nm1723
- Received: 21 September 2007
- Accepted: 04 January 2008
- Published: 10 February 2008
- Issue Date: March 2008
- DOI: https://doi.org/10.1038/nm1723